Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

Por Albers, HM, Wessels, JAM, Straaten, RJH van der, Brinkman, DMC, Suijlekom-Smit, LWA, Kamphuis, SSM, Girschick, HJ, Wouters, C, Schilham, MW, le Cessie, S, Huizinga, TWJ, ten Cate, R, Guchelaar, HJ
Publicado em 2008

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer

Por Diekstra, MH, Fritsch, A, Kanefendt, F, Swen, JJ, Moes, DJAR, Sörgel, F, Kinzig, M, Stelzer, C, Schindele, D, Gauler, T, Hauser, S, Houtsma, D, Roessler, M, Moritz, B, Mross, K, Bergmann, L, Oosterwijk, E, Kiemeney, LA, Guchelaar, HJ, Jaehde, U
Publicado no CPT Pharmacometrics Syst Pharmacol (2017)